drugset / Trial / NCT02551003

Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy

NCT02551003

RandomizedParallel-groupSingle-blindTreatment

Summary

This study examines the effect of cord blood in the treatment of newborn infants with neonatal encephalopathy in combination with hypothermia, which is the standard treatment for this condition. The hypothesis is that the cord blood + hypothermia combination will produce better neuroprotection than the standard treatment of hypothermia alone.

Timeline

Start
2015-09-08
Primary completion
2016-12-30
Completion
2016-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous cord blood Cell therapy Intravenous